{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:07:19Z","timestamp":1789499239307,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40263-025-01231-2","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:14:43Z","timestamp":1759299283000},"page":"1221-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Antiseizure Medications on Lipid Profile and Weight in Patients with Epilepsy: A Systematic Review with Meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1771-0593","authenticated-orcid":false,"given":"Pawe\u0142","family":"Chocho\u0142","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9267-9531","authenticated-orcid":false,"given":"Natalia","family":"Arturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-5417","authenticated-orcid":false,"given":"Pawe\u0142 Marek","family":"\u0141ajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4467-611X","authenticated-orcid":false,"given":"Aisha","family":"Rizwan Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5737-4474","authenticated-orcid":false,"given":"Aishwarya","family":"Koppanatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-2909","authenticated-orcid":false,"given":"Thomas C.","family":"Varkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"publisher","unstructured":"Ali A. Asadi-Pooya, Michael R. Sperling antiseizure medications: antiseizure medications and metabolic disorders. In: A clinician\u2019s manual (3rd ed). 2022. pp. 187\u2013192. https:\/\/doi.org\/10.1093\/med\/9780197541210.003.0014","DOI":"10.1093\/med\/9780197541210.003.0014"},{"key":"1231_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1015691","author":"L Zhuo","year":"2022","unstructured":"Zhuo L, Zhang Y. Effects of new antiseizure medication on bone metabolism and bone mineral density in children: a meta-analysis. Front Pediatr. 2022. https:\/\/doi.org\/10.3389\/fped.2022.1015691.","journal-title":"Front Pediatr"},{"key":"1231_CR3","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"issue":"24","key":"1231_CR4","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313\u201330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962.","journal-title":"Eur Heart J"},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/1047-2797(92)90033-m","volume":"2","author":"WP Castelli","year":"1992","unstructured":"Castelli WP, Anderson K, Wilson PWF, Levy D. Lipids and risk of coronary heart disease. The Framingham study. Ann Epidemiol. 1992;2:23\u20138. https:\/\/doi.org\/10.1016\/1047-2797(92)90033-m.","journal-title":"Ann Epidemiol"},{"issue":"8","key":"1231_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.res.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764\u201372. https:\/\/doi.org\/10.1161\/01.res.0000146094.59640.13.","journal-title":"Circ Res"},{"issue":"24","key":"1231_CR7","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.jacc.2021.04.059","volume":"77","author":"S Raposeiras-Roubin","year":"2021","unstructured":"Raposeiras-Roubin S, Rossell\u00f3 X, Oliva B, et al. Triglycerides and residual atherosclerotic risk. J Am Coll Cardiol. 2021;77(24):3031\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.059.","journal-title":"J Am Coll Cardiol"},{"key":"1231_CR8","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137:e67\u2013492.","journal-title":"Circulation"},{"issue":"19","key":"1231_CR9","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"issue":"4","key":"1231_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.pedhc.2019.02.009","volume":"33","author":"C Elkins","year":"2019","unstructured":"Elkins C, et al. Clinical practice recommendations for pediatric dyslipidemia. J Pediatr Health Care. 2019;33(4):494\u2013504. https:\/\/doi.org\/10.1016\/j.pedhc.2019.02.009.","journal-title":"J Pediatr Health Care"},{"issue":"9","key":"1231_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.seizure.2014.05.011","volume":"23","author":"N Katsiki","year":"2014","unstructured":"Katsiki N, et al. The effects of antiepileptic drugs on vascular risk factors: a narrative review seizure. Eur J Epilepsy. 2014;23(9):677\u201384. https:\/\/doi.org\/10.1016\/j.seizure.2014.05.011.","journal-title":"Eur J Epilepsy"},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","volume":"113","author":"MV Vyas","year":"2015","unstructured":"Vyas MV, Davidson BA, Escalaya L, Costella J, Saposnik G, Burneo JG. Antiepileptic drug use for treatment of epilepsy and dyslipidemia: systematic review. Epilepsy Res. 2015;113:44\u201367. https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.03.002.","journal-title":"Epilepsy Res"},{"issue":"1\u20132","key":"1231_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","volume":"107","author":"V Belcastro","year":"2013","unstructured":"Belcastro V, D\u2019Egidio C, Striano P, Verrotti A. Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res. 2013;107(1\u20132):1\u20138. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.08.016.","journal-title":"Epilepsy Res"},{"issue":"9","key":"1231_CR14","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1111\/jcmm.14464","volume":"23","author":"R Li","year":"2019","unstructured":"Li R, Qin X, Liang X, Liu M, Zhang X. Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid. J Cell Mol Med. 2019;23(9):6017\u201323. https:\/\/doi.org\/10.1111\/jcmm.14464.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1231_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11005","volume":"12","author":"H B\u00fcy\u00fckg\u00f6l","year":"2020","unstructured":"B\u00fcy\u00fckg\u00f6l H, G\u00fcne\u015f M. The effects of antiepileptic medications on lipid profile, thyroid panel, and vitamin level. Cureus. 2020;12(10):e11005. https:\/\/doi.org\/10.7759\/cureus.11005.","journal-title":"Cureus."},{"issue":"10","key":"1231_CR16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/epi.14554","volume":"59","author":"S Mintzer","year":"2018","unstructured":"Mintzer S, Trinka E, Kraemer G, Chervoneva I, Werhahn KJ. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly. Epilepsia. 2018;59(10):1899\u2013907. https:\/\/doi.org\/10.1111\/epi.14554.","journal-title":"Epilepsia"},{"key":"1231_CR17","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.4 (updated August 2023). Cochrane, 2023. www.training.cochrane.org\/handbook."},{"key":"1231_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range and\/or mid-quartile range. Stat Med Res. 2018;27:1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Med Res"},{"key":"1231_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"1231_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1468-1331.2012.03708.x","volume":"19","author":"K Phabphal","year":"2012","unstructured":"Phabphal K, Limapichat K, Sathirapanya P, Setthawatcharawanich S, Geater A. Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population. Eur J Neurol. 2012;19(9):1228\u201334. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03708.x.","journal-title":"Eur J Neurol"},{"key":"1231_CR22","unstructured":"Higgins JPT, Li T, Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.5."},{"key":"1231_CR23","unstructured":"Rugge B, Balshem H, Sehgal R, et al. Screening and treatment of subclinical hypothyroidism or hyperthyroidism. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. (Comparative effectiveness reviews, no. 24.) Appendix A, Lipid Conversion Factors. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83505\/."},{"issue":"355","key":"1231_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"12","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;12(355):i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153\u201360. https:\/\/doi.org\/10.1136\/ebmental-2019-300117.","journal-title":"Evid Based Ment Health"},{"key":"1231_CR26","doi-asserted-by":"publisher","unstructured":"Mathur, Maya B. Sensitivity analysis for the interactive effects of internal bias and publication bias in meta-analyses. OSF Preprints. 2022. https:\/\/doi.org\/10.31219\/osf.io\/u7vcb.","DOI":"10.31219\/osf.io\/u7vcb"},{"issue":"3","key":"1231_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","journal-title":"J Stat Softw"},{"key":"1231_CR28","doi-asserted-by":"publisher","DOI":"10.1201\/9781003107347","volume-title":"Doing meta-analysis with R: a hands-on guide","author":"M Harrer","year":"2021","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert D. Doing meta-analysis with R: a hands-on guide. 1st ed. Boca Raton: Chapman and Hall\/CRC; 2021. https:\/\/doi.org\/10.1201\/9781003107347.","edition":"1"},{"key":"1231_CR29","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.","edition":"2"},{"key":"1231_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"1","key":"1231_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15197\/sabad.1.12.10","volume":"12","author":"D Aksoy","year":"2015","unstructured":"Aksoy D, Solmaz V, \u00c7evik B, Pekda\u015f E, Kurt S. Serum lipids and thyroid functions in young epileptic patients undergoing monotherapy with valproate or levetiracetam. Eur J Gen Med. 2015;12(1):59\u201363. https:\/\/doi.org\/10.15197\/sabad.1.12.10.","journal-title":"Eur J Gen Med"},{"issue":"1","key":"1231_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","volume":"53","author":"YC Chuang","year":"2012","unstructured":"Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53(1):120\u20138. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03316.x.","journal-title":"Epilepsia"},{"issue":"4","key":"1231_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/17512433.2016.1131123","volume":"9","author":"SA Hamed","year":"2016","unstructured":"Hamed SA, Fathy RA, Radwan ME, Abdellah MM. Fatty liver in adults receiving antiepileptic medications: relationship to the metabolic risks. Expert Rev Clin Pharmacol. 2016;9(4):617\u201324. https:\/\/doi.org\/10.1586\/17512433.2016.1131123.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"1231_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","volume":"86","author":"G Luef","year":"2009","unstructured":"Luef G, Rauchenzauner M, Waldmann M, Sturm W, Sandhofer A, Seppi K, et al. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Res. 2009;86(1):42\u20137. https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.04.004.","journal-title":"Epilepsy Res"},{"issue":"8","key":"1231_CR35","doi-asserted-by":"publisher","first-page":"HC05","DOI":"10.7860\/JCDR\/2014\/8744.4682","volume":"8","author":"K Manimekalai","year":"2014","unstructured":"Manimekalai K, Visakan B, Salwe KJ, Murugesan S. Evaluation of effect of antiepileptic drugs on serum lipid profile among young adults with epilepsy in a tertiary care hospital in Pondicherry. J Clin Diagn Res JCDR. 2014;8(8):HC05-HC9. https:\/\/doi.org\/10.7860\/JCDR\/2014\/8744.4682.","journal-title":"J Clin Diagn Res JCDR"},{"issue":"4","key":"1231_CR36","first-page":"MT50","volume":"10","author":"T Nikolaos","year":"2004","unstructured":"Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, et al. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit. 2004;10(4):MT50\u20132.","journal-title":"Med Sci Monit"},{"key":"1231_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2018.06.003","volume":"60","author":"Y Nisha","year":"2018","unstructured":"Nisha Y, Bobby Z, Wadwekar V. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid. Seizure. 2018;60:57\u201360. https:\/\/doi.org\/10.1016\/j.seizure.2018.06.003.","journal-title":"Seizure"},{"issue":"6","key":"1231_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.pharep.2016.09.001","volume":"68","author":"E P\u0142onka-P\u00f3\u0142torak","year":"2016","unstructured":"P\u0142onka-P\u00f3\u0142torak E, Zagrodzki P, Kryczyk-Kozio\u0142 J, Westermarck T, Kaipainen P, Kaski M, et al. Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids. Pharmacol Rep. 2016;68(6):1339\u201344. https:\/\/doi.org\/10.1016\/j.pharep.2016.09.001.","journal-title":"Pharmacol Rep"},{"issue":"4","key":"1231_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1212\/01.wnl.0000048209.07526.86","volume":"60","author":"V Pylv\u00e4nen","year":"2003","unstructured":"Pylv\u00e4nen V, Knip M, Pakarinen AJ, Turkka J, Kotila M, R\u00e4tty\u00e4 J, et al. Fasting serum insulin and lipid levels in men with epilepsy. Neurology. 2003;60(4):571\u20134. https:\/\/doi.org\/10.1212\/01.wnl.0000048209.07526.86.","journal-title":"Neurology"},{"issue":"2","key":"1231_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.17712\/nsj.2017.2.20160342","volume":"22","author":"NA Zuberi","year":"2017","unstructured":"Zuberi NA, Baig M, Bano S, Batool Z, Haider S, Perveen T. Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment. Neurosciences (Riyadh, Saudi Arabia). 2017;22(2):114\u20138. https:\/\/doi.org\/10.17712\/nsj.2017.2.20160342.","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"issue":"10","key":"1231_CR41","first-page":"855","volume":"45","author":"P Dewan","year":"2008","unstructured":"Dewan P, Aggarwal A, Faridi MM. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests. Indian Pediatr. 2008;45(10):855\u20138.","journal-title":"Indian Pediatr"},{"issue":"1","key":"1231_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0920-1211(00)00119-4","volume":"41","author":"J Eir\u00eds","year":"2000","unstructured":"Eir\u00eds J, Novo-Rodr\u00edguez MI, Del R\u00edo M, Meseguer P, Del R\u00edo MC, Castro-Gago M. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000;41(1):1\u20137. https:\/\/doi.org\/10.1016\/s0920-1211(00)00119-4.","journal-title":"Epilepsy Res"},{"issue":"2","key":"1231_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.braindev.2019.11.004","volume":"42","author":"E Karatoprak","year":"2020","unstructured":"Karatoprak E, Tosun O. Effects of valproic acid and levetiracetam monotherapy on carotid intima-media and epicardial adipose tissue thickness in non-obese children with epilepsy. Brain Develop. 2020;42(2):165\u201370. https:\/\/doi.org\/10.1016\/j.braindev.2019.11.004.","journal-title":"Brain Develop"},{"issue":"11","key":"1231_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/ped.14674","volume":"63","author":"H Kilic","year":"2021","unstructured":"Kilic H, Demirel A, Uysal S. The effects of valproate on serum leptin, insulin, and lipid levels in epileptic children. Pediatr Int. 2021;63(11):1351\u20136. https:\/\/doi.org\/10.1111\/ped.14674.","journal-title":"Pediatr Int"},{"issue":"7","key":"1231_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/j.1528-1167.2005.34304.x","volume":"46","author":"K Mikkonen","year":"2005","unstructured":"Mikkonen K, Knip M, Pakarinen AJ, Lanning P, Isoj\u00e4rvi JI, Vainionp\u00e4\u00e4 LK. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation. Epilepsia. 2005;46(7):1114\u201320. https:\/\/doi.org\/10.1111\/j.1528-1167.2005.34304.x.","journal-title":"Epilepsia"},{"key":"1231_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X231200205","volume":"10","author":"KA Nasef","year":"2023","unstructured":"Nasef KA, Elmala MK, Sayed Ahmed AM, Al-Shokary AH, Ibrahim AO, Kamal NM, et al. The study of carotid artery intima-media thickness in children with epilepsy on anti-epileptic drugs. Glob Pediatr Health. 2023;10:2333794X231200205. https:\/\/doi.org\/10.1177\/2333794X231200205.","journal-title":"Glob Pediatr Health"},{"issue":"7","key":"1231_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00431-010-1366-5","volume":"170","author":"O Ozdemir","year":"2011","unstructured":"Ozdemir O, Yakut A, Dinleyici EC, Aydogdu SD, Yarar C, Colak O. Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid. Eur J Pediatr. 2011;170(7):873\u20137. https:\/\/doi.org\/10.1007\/s00431-010-1366-5.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"1231_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3923\/pjbs.2012.68.77","volume":"15","author":"DA Saleh","year":"2012","unstructured":"Saleh DA, Ismail MA, Ibrahim AM. Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. Pak J Biol Sci. 2012;15(2):68\u201377. https:\/\/doi.org\/10.3923\/pjbs.2012.68.77.","journal-title":"Pak J Biol Sci"},{"issue":"7","key":"1231_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s004310050664","volume":"156","author":"DT S\u00f6z\u00fcer","year":"1997","unstructured":"S\u00f6z\u00fcer DT, Atakil D, Dogu O, Baybas S, Arpaci B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr. 1997;156(7):565\u20137. https:\/\/doi.org\/10.1007\/s004310050664.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1231_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1440-1754.1997.tb01588.x","volume":"33","author":"A Verrotti","year":"1997","unstructured":"Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health. 1997;33(3):242\u20135. https:\/\/doi.org\/10.1111\/j.1440-1754.1997.tb01588.x.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"1231_CR51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1442-200x.1997.tb03749.x","volume":"39","author":"E Yal\u00e7in","year":"1997","unstructured":"Yal\u00e7in E, Hassanzadeh A, Mawlud K. The effects of long-term anticonvulsive treatment on serum lipid profile. Acta Paediatr Jpn Overseas Ed. 1997;39(3):342\u20135. https:\/\/doi.org\/10.1111\/j.1442-200x.1997.tb03749.x.","journal-title":"Acta Paediatr Jpn Overseas Ed"},{"issue":"4","key":"1231_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/0883073814551388","volume":"30","author":"RM El-Farahaty","year":"2015","unstructured":"El-Farahaty RM, El-Mitwalli A, Azzam H, Wasel Y, Elrakhawy MM, Hasaneen BM. Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study. J Child Neurol. 2015;30(4):451\u20137. https:\/\/doi.org\/10.1177\/0883073814551388.","journal-title":"J Child Neurol"},{"issue":"2","key":"1231_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00002826-199404000-00010","volume":"17","author":"C Erminio","year":"1994","unstructured":"Erminio C, Ferini-Strambi L, Calori G, Zamboni M, Iannaccone S, Smirne S. Effect of chronic antiepileptic treatment on biochemical parameters. Clin Neuropharmacol. 1994;17(2):199.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"1231_CR54","doi-asserted-by":"publisher","first-page":"859","DOI":"10.35124\/bca.2020.20.1.859","volume":"20","author":"NN Hana","year":"2020","unstructured":"Hana NN, Taha MA, Abass KS. Vascular biomarkers study among epileptic patients with monotherapy. Biochem Cell Arch. 2020;20(1):859\u201368. https:\/\/doi.org\/10.35124\/bca.2020.20.1.859.","journal-title":"Biochem Cell Arch"},{"key":"1231_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01372.x","author":"S Svalheim","year":"2010","unstructured":"Svalheim S, Luef G, Rauchenzauner M, M\u00f8rkrid L, Gjerstad L, Taub\u00f8ll E. Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. Acta Neurol Scand. 2010. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01372.x.","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"1231_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.eplepsyres.2013.08.011","volume":"107","author":"N Sankhyan","year":"2013","unstructured":"Sankhyan N, Gulati S, Hari S, Kabra M, Ramakrishnan L, Kalra V. Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study. Epilepsy Res. 2013;107(1\u20132):121\u20136. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.08.011.","journal-title":"Epilepsy Res"},{"issue":"3","key":"1231_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/jpn.jpn_228_20","volume":"17","author":"K Bhadran","year":"2022","unstructured":"Bhadran K, Bhavani N, Vinayan. Metabolic effects of long-term antiepileptic drug therapy in South Indian children. J Pediatr Neurosci. 2022;17(3):203\u20138. https:\/\/doi.org\/10.4103\/jpn.jpn_228_20.","journal-title":"J Pediatr Neurosci"},{"issue":"2","key":"1231_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.51248\/.v39i2.188","volume":"39","author":"K Singh","year":"2019","unstructured":"Singh K, Kaur H, Singh P. Effect of antiepileptic drugs on various lipid fractions and certain liver enzymes in epileptic patients of Punjab origin. Biomedicine. 2019;39(2):244\u201351. https:\/\/doi.org\/10.51248\/.v39i2.188.","journal-title":"Biomedicine"},{"issue":"3","key":"1231_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-231890","volume":"13","author":"G Bhatt","year":"2020","unstructured":"Bhatt G, Goel S, Shergill G. One size doesn\u2019t fit all: contouring and addressing social vitals in reversing tobacco epidemic in Punjab, India. BMJ Case Rep. 2020;13(3):e231890. https:\/\/doi.org\/10.1136\/bcr-2019-231890.","journal-title":"BMJ Case Rep"},{"issue":"13","key":"1231_CR60","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.2022.3880","volume":"327","author":"AM Kanner","year":"2022","unstructured":"Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: a review. J Am Med Assoc. 2022;327(13):1269\u201381. https:\/\/doi.org\/10.1001\/jama.2022.3880.","journal-title":"J Am Med Assoc"},{"issue":"1","key":"1231_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","volume":"54","author":"MJ Brodie","year":"2013","unstructured":"Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia. 2013;54(1):11\u201327. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03671.x.","journal-title":"Epilepsia"},{"key":"1231_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.seizure.2016.03.002","volume":"37","author":"SS Nair","year":"2016","unstructured":"Nair SS, Harikrishnan S, Sarma PS, Thomas SV. Metabolic syndrome in young adults with epilepsy. Seizure. 2016;37:61\u20134. https:\/\/doi.org\/10.1016\/j.seizure.2016.03.002.","journal-title":"Seizure"},{"key":"1231_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.08.027","volume":"127","author":"Y Yamamoto","year":"2016","unstructured":"Yamamoto Y, Terada K, Takahashi Y, Imai K, Kagawa Y, Inoue Y. Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients. Epilepsy Res. 2016;127:101\u20136. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.027.","journal-title":"Epilepsy Res"},{"key":"1231_CR64","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.21615","volume":"65","author":"S Mintzer","year":"2009","unstructured":"Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, et al. Effects of antiepileptic drugs on lipids, homocysteine and C-reactive protein. Ann Neurol. 2009;65:448\u201356. https:\/\/doi.org\/10.1002\/ana.21615.","journal-title":"Ann Neurol"},{"issue":"5","key":"1231_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0887-8994(98)00084-8","volume":"19","author":"A Verotti","year":"1998","unstructured":"Verotti A, et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol. 1998;19(5):364\u20137. https:\/\/doi.org\/10.1016\/s0887-8994(98)00084-8.","journal-title":"Pediatr Neurol"},{"key":"1231_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1472-8206.2005.00341.x","volume":"19","author":"M Strolin Benedetti","year":"2005","unstructured":"Strolin Benedetti M, Ruty B, Baltes E. Induction of endogenous pathways by antiepileptics and clinical implications. Fundam Clin Pharmacol. 2005;19:511\u201329. https:\/\/doi.org\/10.1111\/j.1472-8206.2005.00341.x.","journal-title":"Fundam Clin Pharmacol"},{"key":"1231_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yebeh.2016.02.023","volume":"58","author":"S Mintzer","year":"2016","unstructured":"Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, et al. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Epilepsy Behav. 2016;58:127\u201332. https:\/\/doi.org\/10.1016\/j.yebeh.2016.02.023.","journal-title":"Epilepsy Behav"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01231-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:07:16Z","timestamp":1762884436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01231-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01231-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable. This is a review article and does not involve original data collection from human or animal participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The data used in this review are available in the cited references.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable. This is a review article and does not involve individual participant data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to this manuscript. P.C. was a lead investigator. P.C. and N.A.\u2014search strategy, selection of included studies, and risk of bias assessment; P.C., N.A., and P.\u0141.\u2014data extraction and writing the paper; P.C. and P.\u0141.\u2014statistics; N.A., P.\u0141., A.K., T.V., and A.R.A.\u2014correcting the manuscript; T.V.\u2014supervision.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}